Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Aadi Bioscience (AADI US)
Watchlist
14
Analysis
Health Care
•
United States
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers. Aadi Bioscience serves patients in the United States.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
12 Nov 2025 06:04
•
Broker
Macro Strategy: Growth Over Differentials
Indonesia’s economy maintained solid momentum in 3Q25, recording 5.04% y-y (1.43% q-q) growth, although slightly easing from 2Q25’s 5.12%.
BRI Danareksa Research
Follow
192 Views
Share
bullish
•
Thematic (Sector/Industry)
•
03 Nov 2025 20:02
•
Broker
BRIDS Market Pulse : Chart of the Week – JCI Market Capitalization
MSCI has outlined two scenarios under this proposed method, which may effectively result in lower weighting for Indonesian stocks in MSCI EM Index.
BRI Danareksa Research
Follow
275 Views
Share
bearish
•
Macroeconomics
•
08 Sep 2025 20:11
•
Broker
BRIDS Market Pulse: Chart of the week – Metal sector vs. gold price
Foreign investors have continued to de-risk on largecap banks, namely BBCA (-US$195mn w-w, YTD: US$1.4bn) and BMRI (- US$45mn w-w, YTD: US$814mn).
BRI Danareksa Research
Follow
331 Views
Share
bearish
•
Thematic (Sector/Industry)
•
12 Aug 2025 19:52
•
Broker
BRIDS Market Pulse: Chart of the Week – JCI P/E Band (10-Year)
MSCI’s Aug25 review announced the inclusion of DSSA and CUAN into the index, with exclusion of ADRO (into MSCI Small Cap).
BRI Danareksa Research
Follow
269 Views
Share
bullish
•
Macroeconomics
•
14 Jul 2025 20:53
•
Broker
Macro Strategy: The Tailwinds and Trade-Off
Liquidity shows early signs of improvement as SRBI yields fall and IndONIA drops; fiscal disbursement expected to lead recovery further.
BRI Danareksa Research
Follow
230 Views
Share
Previous
1
2
3
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x